The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial

EuroIntervention 2016;12:1279-1287. DOI: 10.4244/EIJV12I10A209

1. Nanjing First Hospital, Nanjing Medical University, Nanjing, China; 2. The General Hospital of Shenyang Military Region, Shenyang, China; 3. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; 4. Fu Wai Hospital, Nation

Aims: The study sought to investigate clinical and multimodality imaging assessment of a bioresorbable sirolimus-eluting scaffold (NeoVas, Lepu Medical, Beijing, China) for patients with

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Coronary covered stents